A Randomized Controlled Trial of a Nurse Delivered Stage-matched Smoking Cessation Intervention to Promote Heart Health of Cardiac Patients

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00563199

Enrollment

1824

Registered

2007-11-26

Start date

2002-03-31

Completion date

2005-12-31

Last updated

2011-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking, Smoking Cessation

Keywords

smoking cessation, smoking behaviors

Brief summary

This study is a randomized controlled trial designed to evaluate the effectiveness of a nurse delivered stage-matched intervention to cardiac patients for cessation of tobacco use. Review of literature shows that there is a clear lack of empirical evidence on (1) using nurses to deliver stage-matched smoking cessation interventions, and (2) the effectiveness of such intervention for cardiac patients in Chinese populations. The ultimate goal of the intervention achieve a higher quit rate in the intervention group than in the controls. In addition, the change in the patient's smoking behaviour such as reduction of the number of cigarettes smoked, and progression to a higher stage of readiness to quit, will also be measured. This study is the first step to address the urgently needed data for (1) promoting the delivery of nurse-run stage-matched smoking cessation interventions to help patients stop smoking, (2) developing smoking cessation policy and programmes in the hospitals and for the health care system, and (3) contributing an evidence-based approach to orientate clinical services towards prevention, so as to reduce premature deaths and the enormous disease burden of our society.

Interventions

BEHAVIORALnurse-delivered stage-matched smoking cessation counseling

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Masking

DOUBLE

Eligibility

Sex/Gender

ALL

Inclusion criteria

* Patient who is admitted to the participating centres and is a current smoker who has smoked daily in the past 7 days prior to hospitalization. * Patient speaks and reads Cantonese/Chinese

Exclusion criteria

* Patient who is clinically too ill and not suitable to complete questionnaire and/or receive intervention. * Patient who does not speak or read Chinese

Design outcomes

Primary

Measure	Time frame
Quitting--to achieve higher quit rate in the cardiac patients (coronary artery disease) who are smokers	continuous abstinence for one month at the time of 3, 6 and 12 month follow up

Secondary

Measure	Time frame
Reduction of the number of cigarettes smoked	at the time of 3, 6 and 12 month follow up
Progression to a higher stage of readiness to quit	at the time of 3, 6 and 12 month follow up

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026